Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$14.37
-0.28%
Mkt Cap $1.51B
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (46 analysts)
$46.80
Range $30.00 – $67.00
Implied Upside
+225.7%
Consensus $46.80 vs current $14.37
NASDAQ·Healthcare·Biotechnology
$14.37
-0.28%
Mkt Cap $1.51B
Buy
0
Hold
1
Sell
0
Price Target (46 analysts)
$46.80
Range $30.00 – $67.00
+225.7%
Consensus $46.80 vs current $14.37